Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
December 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
ESMO 2023 - Small Cell Lung Cancer
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
March/April 2012, Vol 5, No 2
Clinical
Benefits of Novel Oral Anticoagulant Agents for Thromboprophylaxis after Total Hip or Knee Arthroplasty
Richard J. Friedman, MD, FRCSC
Stakeholder Perspective
A Paradigm Shift in Anticoagulation?
by
Atheer A. Kaddis, PharmD
Read More
Editorial
A New Beginning
David B. Nash, MD, MBA
Read More
Business
Trends in Biologic Therapies for Rheumatoid Arthritis: Results from a Survey of Payers and Providers
Rhonda Greenapple, MSPH
Stakeholder Perspective
Biologic Therapies for Rheumatoid Arthritis: It's All about Value
by
Albert Tzeel, MD, MHSA, CPE, FAAPL
Read More
Business
Impact of the Removal of the Monthly Liver Function Test Requirement for Ambrisentan
Louise A. Durst, RN
,
John Carlsen, MHA
,
Megan Kuchinski, MPH
,
Lauren Harner, JD
,
Daniel Neves, BA
,
Stephanie J. Harris, RN, BSN
,
Glenna L. Traiger, RN, MSN, CNS-BC
Stakeholder Perspective
The Challenges of Pulmonary Arterial Hypertension Management: Potential Benefits of Removing Monthly Testing
by
James T. Kenney, RPh, MBA
Read More
Results 1 - 4 of 4